Flow cytometric assessment of the T cell activation marker programmed cell death protein 1 (PD-1), an important target of immune checkpoint inhibition, revealed that PD-1 expression in tumor-infiltrating CD8+ and CD4+ T cells was comparable between NSG, NSG-Quad, and MISTRG-6 mice (Figure S8E). This evidence concerns the gene PDCD1 and neoplasm.